PT Medikaloka Hermina Tbk (IDX:HEAL)

Silk Road Medical Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	6,703,240	6,717,179	5,784,086	4,901,810	5,869,014	4,416,042
Revenue Growth (YoY)	9.21%	16.13%	18.00%	-16.48%	32.90%	21.62%
Cost of Revenue	4,500,005	4,429,608	3,863,841	3,333,002	3,085,874	2,493,670
Gross Profit	2,203,235	2,287,571	1,920,245	1,568,808	2,783,140	1,922,372
Selling, General & Admin	953,742	975,524	877,739	850,882	946,678	845,214
Other Operating Expenses	-28,766	-22,843	-36,771	-71,588	-29,844	-65,149
Operating Expenses	1,212,236	1,227,995	1,102,775	980,864	1,018,100	887,026
Operating Income	990,999	1,059,576	817,470	587,944	1,765,040	1,035,346
Interest Expense	-196,604	-179,099	-139,560	-139,833	-143,196	-128,807
Interest & Investment Income	24,358	28,029	31,978	32,548	23,232	32,881
EBT Excluding Unusual Items	818,753	908,506	709,888	480,659	1,645,076	939,420
Gain (Loss) on Sale of Investments	-72	-72	9	-21	2,437	6,749
Gain (Loss) on Sale of Assets	1,088	1,071	845	632	399	418
Asset Writedown	-2,853	-2,356	-349	-1,182	-1,419	-577
Pretax Income	816,916	907,149	710,393	480,088	1,646,493	946,010
Income Tax Expense	211,095	218,020	151,109	101,315	355,852	300,372
Earnings From Continuing Operations	605,821	689,129	559,284	378,773	1,290,641	645,638
Minority Interest in Earnings	-136,096	-153,187	-121,938	-80,177	-294,667	-172,416
Net Income	469,725	535,942	437,346	298,596	995,974	473,222
Net Income to Common	469,725	535,942	437,346	298,596	995,974	473,222
Net Income Growth	-9.56%	22.54%	46.47%	-70.02%	110.47%	85.31%
Shares Outstanding (Basic)	15,001	14,842	14,501	14,464	14,705	14,828
Shares Outstanding (Diluted)	15,001	14,842	14,713	14,714	14,909	14,886
Shares Change (YoY)	1.53%	0.88%	-0.01%	-1.31%	0.16%	-1.34%
EPS (Basic)	31.31	36.11	30.16	20.64	67.73	31.91
EPS (Diluted)	31.31	36.11	29.73	20.29	66.80	31.79
EPS Growth	-10.96%	21.46%	46.52%	-69.63%	110.14%	87.84%
Free Cash Flow	-1,083,363	-1,144,368	-271,707	-261,272	642,792	236,833
Free Cash Flow Per Share	-72.22	-77.10	-18.47	-17.76	43.11	15.91
Dividend Per Share	10.500	10.500	8.500	7.000	6.000	5.000
Dividend Growth	23.53%	23.53%	21.43%	16.67%	20.00%	108.33%
Gross Margin	32.87%	34.06%	33.20%	32.01%	47.42%	43.53%
Operating Margin	14.78%	15.77%	14.13%	11.99%	30.07%	23.45%
Profit Margin	7.01%	7.98%	7.56%	6.09%	16.97%	10.72%
Free Cash Flow Margin	-16.16%	-17.04%	-4.70%	-5.33%	10.95%	5.36%
EBITDA	1,729,264	1,742,906	1,457,621	1,137,579	2,195,538	1,326,687
EBITDA Margin	25.80%	25.95%	25.20%	23.21%	37.41%	30.04%
D&A For EBITDA	738,265	683,330	640,151	549,635	430,498	291,341
EBIT	990,999	1,059,576	817,470	587,944	1,765,040	1,035,346
EBIT Margin	14.78%	15.77%	14.13%	11.99%	30.07%	23.45%
Effective Tax Rate	25.84%	24.03%	21.27%	21.10%	21.61%	31.75%

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.